Iceland· IS-EU/1/25/1943/001
Alyftrek
A deutivacaftor, tezacaftor and vanzacaftor product containing tezacaftorum inn,vanzacaftor calcium dihydrate,deutivacaftor, registered in Iceland by Vertex Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Deutivacaftor, tezacaftor and vanzacaftor is registered in 11 of 19 countries.
Countries holding a registration under ATC R07AX33 (deutivacaftor, tezacaftor and vanzacaftor), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Deutivacaftor, tezacaftor and vanzacaftor · ATC R07AX33
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Tezacaftorum INN,Vanzacaftor calcium dihydrate,Deutivacaftor
- Manufacturer
- Vertex Pharmaceuticals (Ireland) Limited
- Country
- Iceland (IS)
- ATC code
- R07AX33
- ATC class
- Deutivacaftor, tezacaftor and vanzacaftor
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Deutivacaftor, tezacaftor and vanzacaftor in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesALYFTREKVertex Pharmaceuticals Incorporated
- CzechiaALYFTREKVertex Pharmaceuticals (Ireland) Limited, Dublin
- FinlandAlyftrekVertex Pharmaceuticals (Ireland) Limited
- United KingdomAlyftrek 125mg/50mg/10mg tabletsVertex Pharmaceuticals (Europe) Ltd
- IrelandAlyftrek 125 mg/50 mg/10 mg film-coated tabletsVertex Pharmaceuticals (Ireland) Limited
- NetherlandsAlyftrek 125 mg/50 mg/10 mg filmomhulde tablettenVertex Pharmaceuticals (Ireland) Limited
- NorwayAlyftrekVertex Pharmaceuticals (Ireland) Limited
- PolandAlyftrekVertex Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Alyftrek
- Norway · Alyftrek
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e0e93fc-21fb-4847-981a-1f92fa5c758b GET /v1/drugs/6e0e93fc-21fb-4847-981a-1f92fa5c758b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "R07AX33",
"marketed": false,
"strength": "50mg/20mg/4 mg",
"ma_number": "EU/1/25/1943/001",
"substance": "Tezacaftorum INN,Vanzacaftor calcium dihydrate,Deutivacaftor",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í lungnalækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45838"
}See everything about deutivacaftor, tezacaftor and vanzacaftor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.